With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.34946-82-2,Copper(II) trifluoromethanesulfonate,as a common compound, the synthetic route is as follows.
Tert-leucine phosphinoazomethinylate potassium salt (100 mg, 0.23 mmol, 1 eq.) and copper bis-triflate Cu(OTf)2 (114 mg, 0.23 mmol, 1 eq.) are placed in a round-bottom flask. Anhydrous THF is then added (9 mL, 40 mL per mmol). The reaction mixture is agitated at room temperature for 1 hour. The solvent is evaporated and the product is dried under reduced pressure. A green powder is obtained (210 mg, 98%).
The synthetic route of 34946-82-2 has been constantly updated, and we look forward to future research findings.
Reference£º
Patent; Mauduit, Marc; Rix, Diane; Crevisy, Christophe; Wencel, Joanna; US2010/267956; (2010); A1;,
Copper catalysis in organic synthesis – NCBI
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”